Time course of anosmia and dysgeusia in patients with mild SARS-CoV-2 infection
Infect Dis (Lond)
.
2020 Aug;52(8):600-602.
doi: 10.1080/23744235.2020.1772992.
Authors
Ruth Levinson
1
2
,
Meital Elbaz
2
3
,
Ronen Ben-Ami
2
3
,
David Shasha
2
3
,
Tal Levinson
2
3
,
Guy Choshen
2
4
,
Ksenia Petrov
2
5
,
Avi Gadoth
2
6
,
Yael Paran
2
4
Affiliations
1
Internal Medicine Clinic, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
2
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
3
Infectious Diseases Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
4
Internal Medicine H, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
5
Clinical Research Unit, Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
6
Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
PMID:
32552475
DOI:
10.1080/23744235.2020.1772992
No abstract available
Publication types
Letter
Comment
MeSH terms
Betacoronavirus
COVID-19
Coronavirus Infections
Disease Progression
Dysgeusia*
Humans
Olfaction Disorders*
Pandemics
Pneumonia, Viral
Retrospective Studies
Risk Factors
SARS-CoV-2